Fight Against Ebola: What Drugs Are in the Pipeline?

The transcript discusses the potential for profit in developing Ebola therapies, highlighting key companies like Mapp Biopharmaceutical, Chimeric, Tekmira, and Fujifilm. It covers the use of experimental drugs, the importance of monkey trials, and the challenges in clinical trials and FDA approval. The discussion also touches on investment opportunities and market reactions, as well as the manufacturing challenges faced by companies in producing these drugs.

What is the significance of monkey trials in the context of Ebola drug development?

How do investors react to news about Ebola drug developments?